Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Standard Pre- and Postoperative Determination of Chromogranin A in Resectable Non-Functioning Pancreatic Neuroendocrine Tumors—Diagnostic Accuracy: NF-pNET and Low Tumor Burden

Jilesen, Anneke P.J., Busch, Olivier R.C., van Gulik, Thomas M., Gouma, Dirk J., Nieveen van Dijkum, Els J.M. · 2014 · Digestive Surgery

Abstract

Background: Chromogranin A (CgA) is often used in metastatic patients with nonfunctioning pancreatic neuroendocrine tumors (NF-pNET). The aim of this study is to assess the diagnostic accuracy of CgA in patients with low tumor burden. Methods: Resectable patients with NF-pNET without metastases at time of diagnosis were included between 2002 and 2013 in the Academic Medical Center of Amsterdam. CgA was determined at time of diagnosis and during follow-up according to a standardized method. The upper reference range was 94 µg/l. Results: Overall, 47 patients were included in this study. CgA was elevated preoperatively in only 10 patients (27%). In the detection of metastases during follow-up, the positive predictive value for CgA was 50% and negative predictive value was 81%. In 50% of the patients with an elevated CgA during follow-up, this test result was false-positive. Conclusions: The diagnostic accuracy of CgA was low preoperatively in patients with resectable NF-pNET and low tumor burden. In the detection of recurrent disease after curative resection of NF-pNET, the diagnostic accuracy of CgA was moderate (50%). We conclude that the routine measurement of CgA at time of diagnosis or during follow-up after curative resection had limited value in patients with resectable NF-pNET.

Overview

Integrity signals

Registry

Crossref · 10.1159/000370007

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 44 references

Research works printed but not linked: 2

  1. 10.1210/jcem.82.8.4145 · DOI · Paper page
  2. 10.1159/000152000 · DOI · Paper page

Cited by

See all 30

Metadata

Authors
Jilesen, A. P. J., Busch, O. R. C., van Gulik, T. M., Gouma, D. J., & Nieveen van Dijkum, E. J. M.
Affiliations
  • Amsterdam UMC Location University of Amsterdam (NL)
  • Amsterdam Gastroenterology Endocrinology Metabolism (NL)
Venue
Digestive Surgery
Publisher
S. Karger AG
Published
2014
Volume
31
Issue
6
Pages
407-414
ISSN
  • 0253-4886 (ISSN-L)
  • 1421-9883
OpenAlex
W2043740725
Cited by
26
References
44
Citations by year
2026: 1 · 2025: 3 · 2024: 1 · 2023: 2 · 2022: 1 · 2021: 2 · 2020: 3 · 2019: 3 · 2018: 5 · 2017: 1 · 2016: 2 · 2015: 2
FWCI
0.22
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Digestive Surgery (publishedVersion)
  • PubMed (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
  • Health Sciences › Medicine › Clinical Neurology › Neurofibromatosis and Schwannoma Cases
Keywords
chromogranin A, nonfunctioning pancreatic neuroendocrine tumors, diagnostic accuracy, tumor burden, metastasis detection, false positives, postoperative follow-up
MeSH terms
Adult, Aged, False Positive Reactions, Female, Humans, Male, Middle Aged, Neoplasm Recurrence, Local, Pancreatic Neoplasms, Postoperative Period, Predictive Value of Tests, Retrospective Studies, Biomarkers, Tumor, Neuroendocrine Tumors, Tumor Burden, Chromogranin A, Preoperative Period

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Standard Pre- and Postoperative Determination of Chromogranin A in Resectable Non-Functioning Pancreatic Neuroendocrine Tumors—Diagnostic Accuracy: NF-pNET and Low Tumor Burden. https://app.cochat.ai/papers/10.1159/000370007
The paper
Jilesen, A. P. J., Busch, O. R. C., van Gulik, T. M., Gouma, D. J., & Nieveen van Dijkum, E. J. M. (2014). Standard Pre- and Postoperative Determination of Chromogranin A in Resectable Non-Functioning Pancreatic Neuroendocrine Tumors—Diagnostic Accuracy: NF-pNET and Low Tumor Burden. Digestive Surgery. https://doi.org/10.1159/000370007

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.